ZA201301389B - Transdermal therapeutic system with crystallization-inhibiting protectitive film (release liner) - Google Patents

Transdermal therapeutic system with crystallization-inhibiting protectitive film (release liner)

Info

Publication number
ZA201301389B
ZA201301389B ZA2013/01389A ZA201301389A ZA201301389B ZA 201301389 B ZA201301389 B ZA 201301389B ZA 2013/01389 A ZA2013/01389 A ZA 2013/01389A ZA 201301389 A ZA201301389 A ZA 201301389A ZA 201301389 B ZA201301389 B ZA 201301389B
Authority
ZA
South Africa
Prior art keywords
protectitive
crystallization
inhibiting
film
release liner
Prior art date
Application number
ZA2013/01389A
Other languages
English (en)
Inventor
Stefan Bracht
Ildiko Terebesi
Thomas Langguth
Original Assignee
Kocide Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44653285&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201301389(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kocide Llc filed Critical Kocide Llc
Publication of ZA201301389B publication Critical patent/ZA201301389B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2013/01389A 2010-09-06 2013-02-22 Transdermal therapeutic system with crystallization-inhibiting protectitive film (release liner) ZA201301389B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102010040299A DE102010040299A1 (de) 2010-09-06 2010-09-06 Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
PCT/EP2011/065204 WO2012031985A1 (de) 2010-09-06 2011-09-02 Transdermale therapeutische systeme mit kristallisationsinhibierender schutzfolie (release liner)

Publications (1)

Publication Number Publication Date
ZA201301389B true ZA201301389B (en) 2021-05-26

Family

ID=44653285

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2013/01389A ZA201301389B (en) 2010-09-06 2013-02-22 Transdermal therapeutic system with crystallization-inhibiting protectitive film (release liner)

Country Status (33)

Country Link
US (2) US8557279B2 (enExample)
EP (1) EP2613771A1 (enExample)
JP (2) JP6104800B2 (enExample)
KR (1) KR20130114127A (enExample)
CN (1) CN103079549B (enExample)
AP (1) AP3586A (enExample)
AR (1) AR082907A1 (enExample)
AU (1) AU2011298892B2 (enExample)
BR (1) BR112013005305A2 (enExample)
CA (1) CA2810103C (enExample)
CL (1) CL2013000636A1 (enExample)
CO (1) CO6690753A2 (enExample)
CR (1) CR20130098A (enExample)
CU (1) CU24172B1 (enExample)
DE (1) DE102010040299A1 (enExample)
DO (1) DOP2013000053A (enExample)
EA (1) EA032575B1 (enExample)
EC (1) ECSP13012477A (enExample)
GT (1) GT201300062A (enExample)
IL (2) IL224980A (enExample)
MA (1) MA34581B1 (enExample)
MX (1) MX2013002602A (enExample)
MY (1) MY162768A (enExample)
NZ (1) NZ607630A (enExample)
PE (2) PE20131138A1 (enExample)
PH (1) PH12013500429A1 (enExample)
SG (2) SG187941A1 (enExample)
TN (1) TN2013000087A1 (enExample)
TW (1) TWI576245B (enExample)
UA (1) UA110217C2 (enExample)
UY (1) UY33590A (enExample)
WO (1) WO2012031985A1 (enExample)
ZA (1) ZA201301389B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI630208B (zh) 2008-12-08 2018-07-21 歐陸斯迪公司 二氫羥戊甲嗎啡
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674618A5 (enExample) 1987-04-02 1990-06-29 Ciba Geigy Ag
WO1990004397A1 (de) * 1988-10-27 1990-05-03 Schering Aktiengesellschaft Berlin Und Bergkamen Mittel zur transdermalen applikation enthaltend gestoden
US5512292A (en) 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
EP0555360A1 (en) 1990-10-29 1993-08-18 Alza Corporation Transdermal contraceptive formulations, methods and devices
DE4210711A1 (de) 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
DE4336557C2 (de) 1993-05-06 1997-07-17 Lohmann Therapie Syst Lts Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung
DE4405898A1 (de) 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
US5762956A (en) 1996-04-24 1998-06-09 Rutgers, The State University Of New Jersey Transdermal contraceptive delivery system and process
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
DE19906152B4 (de) 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
AU784196B2 (en) 1999-11-24 2006-02-23 Agile Therapeutics, Inc. Improved transdermal contraceptive delivery system and process
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
WO2002045701A2 (en) 2000-12-05 2002-06-13 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems
EP1216699A1 (de) 2000-12-21 2002-06-26 Schering Aktiengesellschaft Transdermalsystem enthaltend ein hochpotentes Gestagen
US20030165547A1 (en) * 2001-05-18 2003-09-04 Elisabeth Picard-Lesboueyries Cosmetic uses of 3beta-acetoxy-7-oxo-DHEA
DE10261696A1 (de) 2002-12-30 2004-07-15 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
NZ541807A (en) * 2003-02-21 2009-07-31 Bayer Schering Pharma Ag UV stable transdermal therapeutic plaster
US8668925B2 (en) * 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
CN1913878B (zh) 2003-12-12 2010-05-26 拜耳先灵医药股份有限公司 无需渗透促进剂的激素透皮传递
UA89766C2 (en) * 2003-12-12 2010-03-10 Байер Шеринг Фарма Акциенгезельшафт Transdermal delivery system of gestodene
ES2596809T3 (es) * 2004-10-08 2017-01-12 Noven Pharmaceuticals, Inc. Dispositivo de administración transdérmica de fármacos que incluye un refuerzo oclusivo
DE102004062182B4 (de) 2004-12-20 2007-06-06 Bayer Schering Pharma Ag Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
CA2739380C (en) * 2008-10-06 2014-12-09 Mylan Technologies, Inc. Amorphous rotigotine transdermal system

Also Published As

Publication number Publication date
CN103079549A (zh) 2013-05-01
UA110217C2 (en) 2015-12-10
ECSP13012477A (es) 2013-04-30
CR20130098A (es) 2013-05-15
SG10201506927TA (en) 2015-10-29
TW201217165A (en) 2012-05-01
CL2013000636A1 (es) 2013-09-13
JP2013536828A (ja) 2013-09-26
KR20130114127A (ko) 2013-10-16
JP6104800B2 (ja) 2017-03-29
CU20130031A7 (es) 2013-05-31
CU24172B1 (es) 2016-04-25
PE20180198A1 (es) 2018-01-26
CO6690753A2 (es) 2013-06-17
US9060955B2 (en) 2015-06-23
MA34581B1 (fr) 2013-10-02
SG187941A1 (en) 2013-04-30
JP2016216500A (ja) 2016-12-22
GT201300062A (es) 2015-01-16
US20140018751A1 (en) 2014-01-16
AP3586A (en) 2016-02-10
CA2810103C (en) 2019-06-18
AU2011298892B2 (en) 2015-03-12
AU2011298892A1 (en) 2013-03-28
AP2013006787A0 (en) 2013-04-30
IL251124B (en) 2020-07-30
EP2613771A1 (de) 2013-07-17
NZ607630A (en) 2015-02-27
MY162768A (en) 2017-07-14
TWI576245B (zh) 2017-04-01
WO2012031985A1 (de) 2012-03-15
UY33590A (es) 2011-10-31
PH12013500429A1 (en) 2019-10-07
US20120082714A1 (en) 2012-04-05
PE20131138A1 (es) 2013-10-26
US8557279B2 (en) 2013-10-15
EA032575B1 (ru) 2019-06-28
TN2013000087A1 (en) 2014-06-25
EA201390246A1 (ru) 2013-09-30
IL224980A (en) 2017-07-31
CA2810103A1 (en) 2012-03-15
IL251124A0 (en) 2017-04-30
DOP2013000053A (es) 2013-07-15
AR082907A1 (es) 2013-01-16
DE102010040299A1 (de) 2012-03-08
BR112013005305A2 (pt) 2016-08-16
MX2013002602A (es) 2013-04-08
CN103079549B (zh) 2016-11-02

Similar Documents

Publication Publication Date Title
EP2775878A4 (en) FOOT ADJUSTMENT SYSTEM FOR SHOES WITH ONE OR TWO TIGHTENING DEVICES
ZA201309297B (en) Tamper-resistant tablet providing immediate drug release
ZA201309299B (en) Tamper-resistant tablet providing immediate drug release
EP2769357A4 (en) MEDICAL DEVICE UPDATE SYSTEM
EP2530111A4 (en) MOVIE
EP2781182A4 (en) PHOTOGRAPHIC DEVICE AND PHOTOGRAPHIC SYSTEM
EP2729032A4 (en) RETENTION SYSTEM HAVING TWO RELEASE MECHANISMS
GB201017546D0 (en) Light inducing drug release
GB201113785D0 (en) Medical line securement system
EP2687374A4 (en) INTERFACE
GB2489710B (en) Nutrient film technique system
IL251124A0 (en) Therapeutic systems through the skin with a protective layer (releasing liner) that inhibits crystallization
EP2589632A4 (en) RADSCHUTZFILM
PL2585549T3 (pl) Luminescencyjna folia rozdzielająca bądź ochronna
IL226375A0 (en) A retaining mechanism for a buckle and a mechanism
PL2386412T3 (pl) Taktowanie posuwu folii
EP2788630A4 (en) ANCHORING SYSTEM
PL2566579T3 (pl) Urządzenie medyczne do magnetoterapii
GB2481139B (en) Interment system
EP2723285A4 (en) MECHANISM FOR REMOVING A MAGNETICALLY TRIGGERED BANDAGE
GB201008428D0 (en) An anchoring system
PL2613772T3 (pl) Plastry transdermalne z niską dawką o wysokim uwalnianiu leku
AU2011901797A0 (en) Emergency Anchor Release System
GB201105842D0 (en) Emergency attached device
GB201016615D0 (en) Drug release composition